MK2-IN-4

• Description:

  MK2-IN-4 is a MAPKAPK2 (MK2) inhibitor with an IC50 value of 45 nM. MK2-IN-4 can be used in the research of cancer, inflammation, immunology[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H315-H319-H335

• Target:

  MAPKAPK2 (MK2)

• Type:

  Reference compound

• Related Pathways:

  MAPK/ERK Pathway

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/mk2-in-4.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1NCC2(CC2)C3=C1C4=C(C5=CC(C6=CC(OCCN7C)=C7C=C6)=NC=C5CC4)N3

• Molecular Formula:

  C25H24N4O2

• Molecular Weight:

  412.48

• Precautions:

  P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362-P403+P233-P405-P501

• References & Citations:

  [1]Schlapbach, et al. Heterocyclic compounds useful as MK2 inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. Patent WO2009010488.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [1105658-32-9]